Feb 24, 2026GLP-1 Agonists and Aging: Metabolic Benefits, Cardiovascular Evidence, and Longevity ImplicationsGLP-1 receptor agonists like semaglutide have demonstrated cardiovascular and metabolic benefits beyond weight reduction. This review covers the mechanistic basis, major trial evidence, and the open questions about their role in longevity medicine.